Veterans Affairs committee  There was a specific call by the CIHR, the Canadian Institutes of Health Research, for research projects around the issue of cannabis and PTSD for veterans specifically. There is research being conducted, yes.

Veterans Affairs committee  The approval and all that is confidential, so I don't have the information, but I'm pretty sure if you addressed that question to CIHR to see what was funded and—

Veterans Affairs committee  For a number of conditions in medicine, we have a number of technology-assisted methods to support rural communities and health care providers in these communities. They would be able to provide the best evidence-based treatment in these communities. That could certainly apply fo

Veterans Affairs committee  I think this information is very important, but again, just to start a process of formal, well-designed evaluation and studies. I think there are no shortcuts, and shortcuts may be dangerous. When you want to treat, and when you want to evaluate a new treatment, there are differ

Veterans Affairs committee  I don't know if I'm allowed to do this, but I would actually ask a question. We have a number of processes already in place to test, to evaluate, to study and to finally approve new medicine and new treatments. The question is actually, why would we do it differently for cannabis

Veterans Affairs committee  Yes. I will not repeat what my colleagues already mentioned. One thing is for sure. I will concur with Dr. Hurd that there are a number of networks in Canada and the U.S. Just in the field of addiction, for example, there are two very strong networks in the U.S. and in Canada th

Veterans Affairs committee  If I may comment on this, I think we need to take a step back. I think that looking at this question with the two possible answers being cannabis and opioid may be misleading. In medicine in general, when we talk about treating a condition, we have guidelines. We have practice

Veterans Affairs committee  The most important piece of research we could do is a well-designed research trial to get the effect of very specific compounds for very specific conditions, and that's what's lacking. I think an anecdotal report, a patient or user reporting positive effects, is very valuable to

Veterans Affairs committee  I'll be speaking to you in French, and I can then answer your questions in both languages. I want to thank the committee for inviting me to appear today to discuss an extremely important issue that affects thousands of men and women who have served this country. These citizens d